S'abonner

Factors associated with discordance in the assessment of fibrosis stage between transient elastography and liver biopsy in NAFLD patients - 11/08/23

Doi : 10.1016/j.clinre.2023.102183 
Meng Lu a, Mingyu Zhu a, Hu Li b, Qingling Wang c, Yuting Qian a, Mingjie Wang a, , Li Chen a,
a Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China 
b Department of Infectious Disease, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, PR China 
c Department of Infectious Disease, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, PR China 

Corresponding author at: Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.Department of GastroenterologyRuijin Hospital, Shanghai Jiao Tong University School of MedicineShanghaiPeople's Republic of China⁎⁎Co-corresponding author.

Highlights

Significant discordance in fibrosis staging between TE and LB:52.9% NAFLD patients.
Higher discordance in F2 (66.3%) and F3 (60.4%) stages, lowest in F4 (0%).
BMI and T2DM associated with M-probe overestimation in fibrosis staging.

Le texte complet de cet article est disponible en PDF.

Abstract

Background and aims

Few studies focus on the concordance of fibrosis stage assessment between transient elastography (TE) and liver biopsy (LB) in non-alcoholic fatty liver disease (NAFLD). This study aimed to investigate the rate of discordance and factors associated with discordance in the fibrosis stage assessment between TE and LB.

Methods

LB-proven NAFLD patients were enrolled retrospectively. Liver fibrosis was assessed via TE and LB based on Steatosis-Activity-Fibrosis (SAF) criteria. Cohen's kappa was used to estimate the discordance between the fibrosis stage assessment by TE and LB. Logistic regression was utilized to determine the factors associated with discordance.

Results

A total of 172 eligible patients were included. The concordance of fibrosis staging between TE and LB was moderate (kappa = 0.446, p < 0.001). The overall rate of discordance was 52.90% (91/172) and highest in the F2 stage (66.28%) and F3 stage (60.42%), moderate in the F1 stage (23.81%), and lowest in the F4 stage (0.00%). The rate of overestimation and underestimation was 23.66% and 38.71% in patients detected by M-probe, while the rate of overestimation and underestimation was 33.87% and 19.35% in patients detected by XL-probe, respectively. BMI [OR=1.494, p = 0.017] and type 2 diabetes mellitus (T2DM) (OR=4.678, p = 0.008) were significantly associated with the overestimation in fibrosis stage assessment when the M-probe was applied.

Conclusions

The discordance between TE and LB in fibrosis stage assessment was unexpectedly high and mainly observed in F1-F3 patients. BMI and T2DM were the factors associated with overestimation using the M-probe.

Le texte complet de cet article est disponible en PDF.

Keywords : Non-alcoholic fatty liver disease, Diagnosis, Fibrosis, Elasticity imaging techniques

Abbreviations : TE, LB, NAFLD, SAF, LSM, BMI, OR, T2DM, NAFL, NASH, SCD, CAP, AASLD, FIB-4, HTN, ALT, AST, GGT, HbA1c, CP, GLU, PLT, HDL, LDL, Fer, IQR/M, SD, CI, AUROC, PPV, NPV, CHB, CHC


Plan


© 2023  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 47 - N° 7

Article 102183- août 2023 Retour au numéro
Article précédent Article précédent
  • Machine learning models predict liver steatosis but not liver fibrosis in a prospective cohort study
  • Behrooz Mamandipoor, Sarah Wernly, Georg Semmler, Maria Flamm, Christian Jung, Elmar Aigner, Christian Datz, Bernhard Wernly, Venet Osmani
| Article suivant Article suivant
  • Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis
  • Abdulrahman Ismaiel, Blal El Hosiny, Mohamed Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Cristina Sorina Catana, Dan L. Dumitrascu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.